Thepharmaletter - thepharmaletter.com
General Information:
Latest News:
Immune Pharma and EpiCept complete merger 27 Aug 2013 | 04:30 pm
Israel-based Immune Pharmaceuticals (Nasdaq OMX Stockholm Exchange: IMNP) says it has now completed its previously-announced merger with US firm EpiCept (The Pharma Letter November 8, 2013, which comb...
Nexavar gains FDA priority review for thyroid cancer sNDA 27 Aug 2013 | 04:26 pm
German drug major Bayer (BAYN: DE) and partner Onyx Pharmaceuticals (Nasdaq: ONXX), which has just agreed a $10.4 billion takeover by Amgen (The Pharma Letter August 27), have been granted Priority Re...
Galderma drug is first FDA-approved facial erythema of rosacea treatment 27 Aug 2013 | 04:21 pm
Switzerland-headquartered Galderma Laboratories says that the US Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (re...
New therapies to spur acute myeloid leukemia market growth 27 Aug 2013 | 04:14 pm
Driven by a boost in new therapies entering the market, as well as an increasing number of acute myeloid leukemia (AML) cases among elderly patients, the AML market will grow significantly between 201...
Sanofi's high dose Fluzone vaccine shows superior efficacy in adults over 65 27 Aug 2013 | 03:21 pm
French drug major Sanofi (Euronext: SAN) has released topline results of a large-scale, multicenter efficacy trial in people 65 years of age and older showing a superior clinical benefit of Fluzone Hi...
Rigel shares fall as asthma compound fails to meet primary endpoint 27 Aug 2013 | 03:17 pm
Shares of USA-based Rigel Pharmaceuticals (Nasdaq: RIGL) fell 10% to $3.27 in morning trading yesterday after it was revealed that the firm's potential asthma treatment R343 did not meet its primary e...
Onyx Pharma accepts increased bid from Amgen 27 Aug 2013 | 01:02 pm
Amgen (Nasdaq: AMGN), the world largest independent biotech group, said on Sunday (August 25) that the board of directors of takeover target Onyx Pharmaceuticals (Nasdaq: ONXX) has approved a transact...
Japan's PM supports reform of drug pricing rules 27 Aug 2013 | 12:58 pm
The Japanese Prime Minister, Shinzo Abe, last week held a meeting of the Council for Regulatory Reform (CRR). The council proposed to the Prime Minister revision of drug pricing rules so as to give hi...
AstraZeneca nabs Amplimmune for $500 million 27 Aug 2013 | 12:53 pm
In a further bid to expand its ailing research portfolio, Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday (August 26) announced that its US subsidiary MedImmune has entered into a definitive...
Russian government to change rules on public procurement of drugs 26 Aug 2013 | 09:37 pm
The Russian government is considering providing permission for the state purchases of essential drugs, in accordance with their brand names, but in line with protection of their chemical formula by pa...
